505(b)(2) formulation for chemotherapy available for in-licensing:
CHP is pleased to announce the availability
- 505(b)(2) formulation for the treatment of chemotherapy induced nausea and vomiting.
- Multiple advantages over currently available products including the ability to use without further reconstitution.
- Polysorbate free.
- Market is both hospital and oncology outpatient clinics
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/505-icon.png
300
300
Jim Usry
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png
Jim Usry2021-10-26 15:52:272021-10-31 18:41:20505(b)(2) formulation for chemotherapy available in-licensing
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/505-icon.png
300
300
Jim Usry
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png
Jim Usry2021-10-26 15:47:292021-10-31 18:41:41505(b)(2) formulation for schizophrenia available in-licensing
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/505-icon.png
300
300
Jim Usry
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png
Jim Usry2021-08-17 15:44:022021-10-31 18:42:01Approved 505(b)(2) available for in-licensing
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/In-License-icon.png
300
300
Jim Usry
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png
Jim Usry2020-10-10 15:36:022021-10-31 18:07:59Chemotherapy induced nausea and vomiting product available for in-licensing
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/In-License-icon.png
300
300
Jim Usry
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png
Jim Usry2020-09-20 15:05:132021-10-31 18:08:31Schizophrenia asset available for in-licensing